OBJECTIVES: Early lung cancer (LC) diagnosis is key to improve prognosis. We explored here the diagnostic performance of a trained dog to discriminate exhaled gas samples obtained from patients with and patients without LC and healthy controls.
INTRODUCTION
Lung cancer (LC) is the first cause of cancer death in the globe [1] . Survival of patients with LC is directly related to the extension of the disease at the time of diagnosis [2] . Unfortunately, 75% of patients with LC are diagnosed when the disease is fairly advanced, since earlier stages are most often asymptomatic. A recent study by the US National Cancer Institute showed that the use of computed tomography improves early diagnosis of LC and decreases mortality by 20% [3] . Yet this is accompanied by the frequent identification of pulmonary nodules that may require invasive diagnostic procedures, not fully exempted of potential complications. Finally, even in symptomatic patients, the differential diagnosis of LC is not always straightforward [4] . Thus, complementary diagnostic techniques are needed.
Exhaled breath contains volatile organic compounds (VOCs) such as isoprenes, alkalenes and benzene derivates. The pattern of exhaled VOCs is altered in several metabolic, neurologic and gastrointestinal diseases, as well as in different cancer types [5] , including LC [6] . The analysis of the exhaled VOC pattern, however, requires sophisticated and expensive methodologies, such as automated thermal desorption, gas chromatography, mass spectrometry or electronic nose [6] [7] [8] [9] . The resolution capacity of canine olfaction is several orders of magnitude higher than the best technology currently available, and dogs are able to discriminate different VOC patterns in the air [10] . This is why they are regularly used by police to smell drug traffic or to find survivors after an earthquake. Previous studies showed that dogs can detect various types of cancer [11] , including melanoma [12] bladder [13] , breast and lung [14] , prostate [15] and colon [16] . In the case of LC, dogs appear able to identify the presence of LC with high accuracy regardless of LC stage, age of the patient and/or smoking status [14] [15] [16] [17] . This raises the possibility that trained dogs can provide added diagnostic value to a computed tomography screening programme. We wish to test this hypothesis in an LC screening programme that is about to start in the reference area of our hospital. To do so, however, we first needed to train †Presented at the 25th European Conference on General Thoracic Surgery, Innsbruck, Austria, 28-31 May 2017. and test the dog. Here, we report our experience with the training process and the diagnostic assessment capabilities of the trained dog when exposed to exhaled gas of patients with and without LC as well as healthy controls.
METHODS

Study design and ethics
This is a prospective, controlled, two-phase study. Phase 1 involved training the dog to identify LC in exhaled gas samples, as explained below. Phase 2 tested prospectively the specificity, sensibility, positive predictive value (PPV) and negative predictive value (NPV) achieved by the dog, once satisfactorily trained, when confronted with samples obtained from individuals with and without LC. This project was approved by the Ethics Committee of our institution (2012/7899), and all participants signed their informed consent.
Participants
From September 2015 until October 2016, we collected 395 samples of exhaled gas from 113 individuals: 85 patients with LC and 28 controls (which included 11 patients without LC and 17 healthy individuals) ( Table 1) . Exclusion criteria were suspicion or confirmation of malignant disease different from LC, previous treatment with chemotherapy or thoracic surgery, tracheostomy and any other endoscopic procedure during the 7 days that preceded the collection of exhaled gas. (15) COPD: chronic obstructive pulmonary disease.
Exhaled gas sampling
Exhaled gas samples were obtained following previously described methodology [17] . In brief, participants refrained to eat and smoke 30 min before sampling. Then, after a deep inspiration, exhaled gas was collected in a 15-cm cylinder-like glass tube open on both ends and filled with 2 wool layers, one of them hydrophobic and the other one hydrophilic (Fig. 1A) . The tubes were then hermetically sealed with silicone caps and stored, not more than 3 months, until exposed to the dog.
Dog training
The dog selected for training was a 3-year-old male cross-breed between a Labrador Retriever and a Pitbull (Fig. 1B) . Training was based on positive reinforcement through a reward-based method aimed at the association of smell patterns. That is, we first exposed the dog to the odour of interest (i.e. exhaled gas of patients with LC only) without distractors (i.e. no controls), followed by a reward (a bit of food), so that he would associate the smell, memorize it and learn to recognize it (Fig. 1B) . At the same moment, in order to establish the way in which the dog will indicate having smelled a sample with LC, he was asked to sit. This training phase was concluded when the dog sat automatically when confronted to a known LC sample. Then, the second phase (testing) started (see below).
Dog testing
Once the dog was considered well trained by an experienced dog trainer, he was tested by exposing him to 5 different exhaled gas samples (1 from a patient with LC and 4 from healthy controls and patients without LC) contained in wood receptacles ( Fig. 2 ; Video 1). The dog was then expected to indicate which sample was coming from the patient with LC by sitting next to it (see Video 1).
Statistical analysis
Because this was a pilot study, we did not formally calculate a minimum sample size. Results are presented as n, proportions and/or mean (±SD), as appropriate. The sensibility, specificity, PPV and NPV and the receiver-operating characteristics curve were calculated using standard formulas.
RESULTS
We studied a total of 113 individuals (85 patients with LC and 28 controls). Table 1 presents their main demographic and clinical data, stratified according to the 2 phases of the study (training and testing). Patients in the LC group were older. Gender distribution was similar between groups. Most patients with LC were ever or current smokers, and some of them had chronic obstructive pulmonary disease of varied severity according to the GOLD classification (Table 1) . For Phase 1, we used 20 samples from patients with LC, whereas 370 samples were used for Phase 2 (230 samples from LC patients and 140 from healthy individuals and patients without LC); 5 samples could not be used because of technical reasons (3 broken recipients and 2 caps could not be removed from the recipient). All in all, the dog was tested 785 times, each testing session using 5 different samples, in order to have analytical independent observations. We found that the trained dog recognized LC in exhaled gas with a sensitivity of 0.95, a specificity of 0.98, a PPV of 0.95 and an NPV of 0.98. The area under the curve of the receiver-operating characteristics curve was 0.971 (Fig. 3 ). 
DISCUSSION
This study shows that a well-trained dog can detect the presence of LC in exhaled gas samples with an extremely high accuracy. In 1989, Williams and Pembroke described in The Lancet the case of a woman who requested the study of a skin lesion because of the interest it caused to her dog [11] . Since then, numerous publications have confirmed the olfactory capacity of trained dogs to detect different types of human cancer [12] [13] [14] [15] [16] . More recently, and within the context of LC, Boedeker et al. compared the diagnostic capacity of trained dogs versus an electronic nose to identify LC and concluded that dogs were more specific and sensitive than the e-nose tested [18] . This same group of investigators also investigated the ability of trained dogs to detect LC in exhaled breath and reported that dogs had a sensibility, of 71% and a specificity of 93% to detect LC [17] . Our results are in keeping with this last study, but our diagnostic accuracy was better since our dog (i) achieved a sensibility of 0.95, a specificity of 0.98, a PPV of 0.95 and an NPV of 0.98 and (ii) the area under the curve of the receiver-operating characteristics curve (not previously reported) was 0.971 (Fig. 3) . Differences may be due to the fact that previous studies used 4 different dogs, whereas ours used only 1, thereby potentially reducing the variability of results.
These results open at least 2 avenues for investigation. First, they will allow us to test the contribution of trained dogs in the early diagnosis of LC in a screening programme we are about to start in our reference population. And, second, they clearly support the need to identify specifically what VOC pattern does the dog identify using advanced technologies such as mass spectrometry. We are also working along this line of investigation and hope to be able to report the results in the near future. 
APPENDIX. CONFERENCE DISCUSSION
Dr Yukio Sato (Tsukuba, Japan): I am really interested in this dog test. I wonder whether you have tried this test before and after the surgery of lung cancer. If dogs can recognize the disappearance of tumour after surgery, it can be used for the assessment of the completeness of the surgery or the follow-up. If the reoccurrence occurs, dogs can detect that reoccurrence. I wonder whether you have tried doing one after the surgery.
Dr Angela Guirao Montes (Barcelona, Spain): We have not tried it in this way that you are talking about. We thought about it, but now we are working on detection of volatile organic compounds. At the beginning of the study, we thought about repeating the test after the surgery, but then we decided to stop doing it this way, because we are working in the other way now with VOC. But I think it would be very interesting to develop this line of investigation.
Dr Thorsten Walles (Magdeburg, Germany): I have 2 questions: Do you suggest that we really apply dogs in all hospitals for the diagnosis of the lung cancer?
Dr Guirao Montes: It would be really much more fun, but we are aware that it is not possible to have a dog in the office, so we think that dogs can be of very big help to develop some kind of gadget or method to detect, maybe volatile organic compounds. But we think that it is not possible to use dogs to do the diagnosis.
Dr Walles: Do you have any experience if it works with every dog that you train?
Dr Guirao Montes: It does not work with all the dogs, because we have tried to train a different dog before Blat and it did not work.
Dr Hidenao Kayawake (Kyoto, Japan): I have 1 simple question. Does the location of the lesion matter? I am not a dog so I cannot imagine the dog's feelings, but I feel that the central tumour is more detectable than the peripheral tumour. How about it?
Dr Guirao Montes: When we took the samples, the stage or location of the lesion did not matter, but then, when we performed the data analysis, we have realized that the dog was able to recognize lesions that were earlier stages and it did not matter whether it was peripheral or whether it was a central lesion. The dog had bigger number of mistakes when the stage was an advanced stage. We thought that maybe it is because the dog smells something, e.g. infection or necrosis of cellular death, not only the 'cancer smell'. But we are not sure about it; it is something that we suppose.
Dr Paula A. Ugalde (Quebec, Canada): Since you probably won't be authorized to enter the dogs in a hospital, have you considered using them in small communities? For instance, I'm from Brazil, and there we have favelas. Those are poor communities with high levels of smoking habits. Could develop a study using the dogs in this type of controlled population groups? Dr Guirao Montes: At the beginning, this was the goal of our study, but as we went further, we thought that maybe it could be very useful in the development of a gadget or a method of the diagnosis, because we thought that having a dog in the office was not possible. At the beginning of our study it was the goal, but investigation always changes during the trial.
Dr Luis Hernandez (Birmingham, UK): I worked in Shanghai for 2 years and there 35% of our lesions right now are GGOs. I want to ask you whether there is any limit in the size or whether you discovered if there is any size that the dog cannot discover. Also, with coming of the screening programmes maybe we will have more GGOs coming for the surgeons. Do you think the dog will be able to discover preinvasive lesions, like adenocarcinoma in situ, AIH or maybe MIA? What is your feeling about your data? Dr Guirao Montes: Our feeling is that the dog is able to detect everything. The smallest lesion that he has detected is a 4-mm adenocarcinoma and we are completely amazed. We do not know whether it is this particular dog or that the method really works. We are working to know about that. But at the moment we can say there are no limits in the lesions that the dog is able to detect.
